Skip to main content

Closed

CLYM: Climb Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-40.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio27.86×

Climb Bio, Inc.

CLYMNASDAQ Global Market·USD·Closed

Climb Bio, Inc.

CLYMNASDAQ·USD·Closed

$11.90

−1.49%

$11.90

−$0.18 (1.49%)

52W Range

81thpctl

Volume

0.50×avg

Mkt Cap

811.39MUSD

P/E

-15.3TTM

Div Yield

–ann

52W Range

81thpctl

Volume

0.50×avg

Market Cap

811.39MUSD

P/E Ratio

-15.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings